Why the study?
Does inhibition of platelet GP Ib, GP IIb/IIIa, or both prevent arterial thrombosis in a baboon model of femoral artery stenosis?
Does inhibition of platelet GP Ib, GP IIb/IIIa, or both prevent arterial thrombosis in a baboon model of femoral artery stenosis?
Inhibition of platelet GP Ib alone or in combination with a low-dose GP IIb/IIIa blocker prevents arterial thrombosis without increasing bleeding time in a baboon model.
Answers are grounded in this paper and cite their sources.
GP Ib inhibition strategies merit human translation studies; leaves open clinical efficacy and bleeding safety in arterial thrombosis.
The antithrombotic efficacy of the monoclonal antibodies 6B4-Fab and MA-16N7C2 against platelet glycoprotein (GP) Ib and GP IIb/IIIa, respectively, on acute platelet-mediated thrombosis was evaluated in a baboon model of femoral artery stenosis, which is a modification of the original Folts model: platelet thrombi form on the injured stenosed artery, producing cyclic flow reductions (CFRs). A dose of 0.6 mg/kg 6B4-Fab significantly reduced the CFRs by 59 +/- 15%, whereas 2 mg/kg 6B4-Fab completely abolished the CFRs without prolongation of the bleeding time. MA-16N7C2 inhibited CFRs by 43 +/- 8% at a dose of 0.1 mg/kg and abolished the CFRs at a dose of 0.3 mg/kg but with a significant prolongation of the bleeding time. Finally, the combination of 0.6 mg/kg 6B4-Fab and 0.1 mg/kg MA-16N7C2 fully prevented the CFRs without prolongation of the bleeding time. The present study demonstrates that the inhibition of platelet GP Ib function by 6B4-Fab is a powerful intervention to prevent platelet thrombus formation in injured arteries without prolongation of the bleeding time; the latter is in contrast to the result after the inhibition of GP IIb/IIIa. Moreover, we demonstrate that combining a GP Ib blocker with a GP IIb/IIIa blocker can achieve a strong antithrombotic effect without increasing the bleeding time. This provides new information that will be beneficial in designing clinical therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: